Evaluation of prime/boost regimens using recombinant poxvirus/tyrosinase vaccines for the treatment of patients with metastatic melanoma.

Source:http://linkedlifedata.com/resource/pubmed/id/16638862

Clin. Cancer Res. 2006 Apr 15 12 8 2526-37

Download in:

View as

General Info

PMID
16638862